Merck, Enigma Biomedical signs license agreement for Novel MK 6884 Imaging Agent Garima20 March 2019 4:16 AM GMTAs part of the agreement with Merck, EBG will be responsible for the clinical development and commercialization of MK-6884 in return for payment of...
Novartis hopeful for novel heart drug, despite modest benefit Ruby Khatun Khatun28 Aug 2017 7:35 AM GMTZURICH: Novartis will seek regulatory approval this year for a new kind of anti-inflammatory heart drug, though some experts fear fatal infection...